MAPT and Alzheimer disease: It has been reported that CRS can promote AD-type pathology in wild type rats and mice, and in transgenic models for AD, including aggregation and deposition of Aβ, hyper-phosphorylation of tau protein, and degeneration and massive loss of neurons, as well as decline in learning and memory ability (Table 1) [7, 17-20].